Core Alternative Capital Laboratory Corp Of America Holdings Transaction History

Core Alternative Capital

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$209.01 - $232.56 $6,479 - $7,209	-31 Reduced 93.94%	2 $0
Q4 2023 Feb 14, 2024	SELL	$197.69 - $227.29 $395 - $454	-2 Reduced 5.71%	33 $7,000
Q2 2023 Jul 27, 2023	BUY	$211.93 - $241.33 $847 - $965	4 Added 12.9%	35 $8,000
Q1 2023 Apr 18, 2023	BUY	$213.32 - $257.83 $426 - $515	2 Added 6.9%	31 $7,000
Q4 2022 Jan 31, 2023	SELL	$203.72 - $248.97 $7,537 - $9,211	-37 Reduced 56.06%	29 $6,000
Q2 2022 Aug 01, 2022	BUY	$213.86 - $277.87 $1,283 - $1,667	6 Added 10.0%	66 $15,000
Q1 2022 May 10, 2022	BUY	$259.82 - $298.18 $14,030 - $16,101	54 Added 900.0%	60 $16,000
Q4 2021 Feb 11, 2022	BUY	$271.6 - $314.21 $1,629 - $1,885	6 New	6 $2,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

Stay updated on Core Alternative Capital with notifications on news.